APD

Investors Eyeing Air Products and Chemicals Stock

Large-cap Industrials company Air Products and Chemicals has logged a 2.2% change today on a trading volume of 2,877,892. The average volume for the stock is 1,603,819.

Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and related services in the Americas, Asia, Europe, the Middle East, India, and internationally. Based in Allentown, United States the company has 23,000 full time employees and a market cap of $58,399,789,056. Air Products and Chemicals currently offers its equity investors a dividend that yields 2.7% per year.

The company is now trading -1.92% away from its average analyst target price of $267.85 per share. The 21 analysts following the stock have set target prices ranging from $210.0 to $355.0, and on average give Air Products and Chemicals a rating of buy.

Over the last 12 months APD shares have declined by -4.5%, which represents a difference of -31.0% when compared to the S&P 500. The stock's 52 week high is $307.71 per share and its 52 week low is $212.24. Based on Air Products and Chemicals's average net margin growth of 1.2% over the last 6 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 12,600,000 2,300,200 18 0.0
2022 12,698,600 2,256,100 18 -10.0
2021 10,323,000 2,099,100 20 -4.76
2020 8,856,300 1,886,700 21 5.0
2019 8,918,900 1,760,000 20 17.65
2018 8,930,200 1,497,800 17
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS